Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

ursement of pharmaceutical products and the settlement of patent litigation; and such other risks and uncertainties detailed in Actavis' periodic public filings with the Securities and Exchange Commission, including but not limited to Actavis' Annual Report on form 10-K for the year ended December 31, 2011 and its Quarterly Report on Form 10-Q for the period ended September 30, 2012 (such periodic public filings having been filed under the "Watson Pharmaceuticals, Inc." name).  Except as expressly required by law, Actavis disclaims any intent or obligation to update these forward-looking statements.

Trademarks noted in this press release are the property of their respective registered owners. CONTACTS: Investors:Lisa DeFrancesco (862) 261-7152Media:Charlie Mayr(862) 261-8030The following table presents Actavis' results of operations for the three and twelve months ended December 31, 2012 and 2011:Table 1Actavis, Inc.Condensed Consolidated Statement of Operations(Unaudited; in millions, except per share amounts)Three Months EndedTwelve Months EndedDecember 31,December 31,2012201120122011Net revenues$
,750.2$
,544.6$
5,914.9$
4,584.4Operating expenses:Cost of sales (excludes amortization, presented below)1,008.0892.73,390.42,564.9Research and development121.167.2401.8295.4Selling, general and administrative424.3213.01,171.3754.9Amortization148.2151.3481.1354.3Loss on asset sales and impairments, net29.953.1149.578.7Total operating expenses1,731.51,377.35,594.14,048.2Operating income 18.7167.3320.8536.2Non-operating income (expense):Interest income1.20.52.52.1Interest expense(54.6)(12.7)(116.7)(81.8)Other income (expense), net151.90.638.5(0.5)Total other income (expense), net98.5(11.6)(75.7)(80.2)Income before income taxes and noncontrolling interest 117.2155.7245.1456.0Provision for income taxes88.261.5146.8196.9Net income29.094.298.3259.1Loss attributable to noncontrolling interest(1.0)0.6(1.0)1.8Net income attributable to common sh
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... patent application concerning composition of matter, biological targets, mechanism ... cell death.  This patent application describes ... RNA molecules (VSRNAs) which interfere with the basic homeostatic ...
(Date:1/15/2014)... 15, 2014 Reportlinker.com announces that a ... its catalogue: PharmaPoint: ... Market Analysis to 2022 ... - India Drug Forecast and Market Analysis ...
(Date:1/15/2014)... wearable injector slightly larger than an Oreo cookie may soon ... drugs in the large doses required to treat a wide ... genetic disorders.  An emerging biologic drugs market ... analysts.   Many of these drugs will require a new type ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
(Date:4/17/2014)... first genetic variant specifically associated with the risk ... 10-15 per cent of all breast cancer cases. ... cancer sub-type, called invasive lobular carcinoma, gives researchers ... particular kind of breast cancer, which can be ... (Thursday) in the journal PloS Genetics , ...
(Date:4/17/2014)... of Experimental Biology and Medicine a ... and Paul Kenis in the Institute of Genomic ... of Illinois Urbana-Champaign describe their recent work on ... variety of cell functions including energy metabolism, signaling, ... in regulating normal cellular behavior, redox status has ...
(Date:4/17/2014)... Bonheur Children,s Hospital Pediatrician-in-Chief Jon McCullers, MD, was ... April issue of Nature Reviews Microbiology , ... Dr. McCullers, a world-renowned infectious disease specialist, and ... University of Tennessee Health Science Center, analyzed the ... 1957 and 1968 pandemics, as well as more ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... School of Medicine (BUSM) have discovered that the ... experimental model. The findings, reported in the ... may lead to more effective treatments for alcoholism. ... the leading causes of illness and death in ... by limiting the productivity of workers and necessitating ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... Bob Hamilton was named Vice,President of Hamilton Medical, Inc. ... a financial background and strong technology,experience that has been ... Vangaurd and Janus Funds, just to name a few. ... is,looking forward to great things for the future., ...
... among teens, but researchers from Tel Aviv University have found ... lip. , Dr. Liran Levin, a dentist from the Department ... University has found that about 15 to 20 percent of ... tooth fractures and gum disease. Resulting tooth fractures as well ...
... Not too late to Protect Your Investment and Vote ... - The Concerned Shareholders remind,fellow shareholders of Biovail that ... for a Better Biovail. It is more than clear ... Equity Research, have today changed,their recommendation for BVF to ...
... Washington -- The American College of Physicians (ACP) today ... recognition of the importance of primary care in a ... to Congress. ACP commended MedPAC in a letter ... independent advisory Commission that advises the U.S. Congress on ...
... and Wilson for introducing "The,21st Century Communications ... WASHINGTON, June 20 The Coalition of,Organizations ... Edward Markey (D-MA) and Heather Wilson (R-NM) ... Accessibility Act of,2008" (H.R. 6320). The bill ...
... on sunscreen-averse teen boys , , FRIDAY, June 20 (HealthDay ... Major League Baseball is gearing up to warn players ... , Major League Baseball, the Major League Baseball Players ... kicking off their 10th annual Play Sun Smart campaign ...
Cached Medicine News:Health News:Warning for teens: Teeth and jewelry don't mix 2Health News:CIBC World Markets Equity Research Downgrades Target Price of BVF from $12.00 to a Staggering Low of $7.50 Based on Potential Incumbent Win in Proxy Battle 2Health News:American College of Physicians commends MedPAC June 2008 report to Congress 2Health News:American College of Physicians commends MedPAC June 2008 report to Congress 3Health News:Legislation Brings Hope for People With Disabilities Left Out of New Communications Technologies 2Health News:Legislation Brings Hope for People With Disabilities Left Out of New Communications Technologies 3Health News:Pro Baseball Helps Keep Skin Cancer From Scoring 2Health News:Pro Baseball Helps Keep Skin Cancer From Scoring 3
The license agreement for the manufacturing and distribution of Bulgari eyewear was signed by Luxottica Group in 1997.,Bulgari eyewear is designed for sleek, select people who want to distinguish the...
... Chanel optical collection, inspired by ... to Mademoiselle's heart, from the ... quilted effect. Combining the purity ... of Strass and other light ...
... eyewear and sunwear, inspired by ... personal style, with long lasting ... the collection include sophistication, elegance ... offer clean modern shapes, classic ...
... frame mounting technology has redefined rimless collections ... taper at the end of each frame ... of the bushing that mounts within the ... a secure fit is created that far ...
Medicine Products: